Update on therapeutic and prophylactic vaccines in HPV associated neoplasia

For prophylactic vaccination questions are being asked regarding the relative value of single versus multiple doses and the anticipation that cross protection will increase with increasing numbers of types of HPV included in the vaccine. As regarding therapetic vaccinationwork is ongoing but it is proving difficult to change events in a lesion that has already happened. Perer Stern tells us more in this video.